Interferon gamma-1b in combination with chemotherapy (carboplatin/paclitaxel) for first line therapy of advanced ovarian or primary peritoneal carcinoma.

Trial Profile

Interferon gamma-1b in combination with chemotherapy (carboplatin/paclitaxel) for first line therapy of advanced ovarian or primary peritoneal carcinoma.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 01 May 2008

At a glance

  • Drugs Carboplatin; Interferon gamma-1b; Paclitaxel
  • Indications Ovarian cancer; Peritoneal cancer
  • Focus Adverse reactions; Registrational; Therapeutic Use
  • Acronyms GRACES
  • Most Recent Events

    • 04 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top